I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Targeted exon skipping of NF1 exon 17 as a therapeutic for ..:
André Leier
;
Marc Moore
;
Hui Liu
...
http://www.sciencedirect.com/science/article/pii/S2162253122000609. , 2022
Link:
https://doi.org/10.1016/j.omtn.2022.03.011
RT Journal T1 <Title>Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:e537f0d08c7e4a27859b8efc3e84fa46&Exemplar=1&LAN=DE A1 André Leier A1 Marc Moore A1 Hui Liu A1 Michael Daniel A1 Alexis M. Hyde A1 Ludwine Messiaen A1 Bruce R. Korf A1 Jamuna Selvakumaran A1 Lukasz Ciszewski A1 Laura Lambert A1 Jeremy Foote A1 Margaret R. Wallace A1 Robert A. Kesterson A1 George Dickson A1 Linda Popplewell A1 Deeann Wallis PB Elsevier YR 2022 K1 MT: Oligonucletides: Therapies and Applications K1 neurofibromatosis type I K1 Ras/Raf/MAPK pathway K1 exon skipping K1 antisense oligo therapeutics K1 animal models K1 Therapeutics. Pharmacology K1 RM1-950 JF http://www.sciencedirect.com/science/article/pii/S2162253122000609 LK http://dx.doi.org/https://doi.org/10.1016/j.omtn.2022.03.011 DO https://doi.org/10.1016/j.omtn.2022.03.011 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
